PMID: 23744072

Chen PC, Olson EM, Zhou Q, Kryukova Y, Sampson HM, Thomas DY, Shyng SL
Carbamazepine as a novel small molecule corrector of trafficking-impaired ATP-sensitive potassium channels identified in congenital hyperinsulinism.
J Biol Chem. 2013 Jul 19;288(29):20942-54. doi: 10.1074/jbc.M113.470948. Epub 2013 Jun 6., [PubMed]
Sentences
No. Mutations Sentence Comment
68 ABCC8 p.Ala116Pro
X
ABCC8 p.Ala116Pro 23744072:68:189
status: NEW
view ABCC8 p.Ala116Pro details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:68:223
status: NEW
view ABCC8 p.Phe27Ser details
Groups of islets (100 islet equivalents) in each well of a 12-well plate were infected with Ad-tTA (m.o.i., 500), Ad-Kir6.2 (m.o.i., 2000), and either Ad-f-SUR1 (m.o.i., 1000) or mutant Ad-A116P f-SUR1 (m.o.i., 1000) or Ad-F27S f-SUR1 (m.o.i., 500) for 16 h in 0.5 ml of Opti-MEM (Invitrogen) at 37 &#b0;C. The islets were then incubated for an additional 24 h in RPMI 1640 medium with 10% FBS containing either DMSO, glibenclamide, or carbamazepine before being harvested for immunoblotting. Login to comment
69 ABCC8 p.Ala116Pro
X
ABCC8 p.Ala116Pro 23744072:69:189
status: NEW
view ABCC8 p.Ala116Pro details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:69:223
status: NEW
view ABCC8 p.Phe27Ser details
Groups of islets (100 islet equivalents) in each well of a 12-well plate were infected with Ad-tTA (m.o.i., 500), Ad-Kir6.2 (m.o.i., 2000), and either Ad-f-SUR1 (m.o.i., 1000) or mutant Ad-A116P f-SUR1 (m.o.i., 1000) or Ad-F27S f-SUR1 (m.o.i., 500) for 16 h in 0.5 ml of Opti-MEM (Invitrogen) at 37 &#b0;C. The islets were then incubated for an additional 24 h in RPMI 1640 medium with 10% FBS containing either DMSO, glibenclamide, or carbamazepine before being harvested for immunoblotting. Login to comment
78 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:78:77
status: NEW
view ABCC8 p.Phe27Ser details
Immunofluorescence Staining-COSm6 cells transfected with WT Kir6.2 and WT or F27S f-SUR1were plated on coverslips 1 day before the experiment and treated overnight with DMSO, tolbutamide, or carbamazepine. Login to comment
79 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:79:77
status: NEW
view ABCC8 p.Phe27Ser details
Immunofluorescence Staining-COSm6 cells transfected with WT Kir6.2 and WT or F27S f-SUR1were plated on coverslips 1 day before the experiment and treated overnight with DMSO, tolbutamide, or carbamazepine. Login to comment
88 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:88:118
status: NEW
view ABCC8 p.Phe27Ser details
Metabolic Labeling and Immunoprecipitation-COSm6 cells were plated on 35-mm dishes and transfected with WT Kir6.2 and F27S f-SUR1. Login to comment
89 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:89:118
status: NEW
view ABCC8 p.Phe27Ser details
Metabolic Labeling and Immunoprecipitation-COSm6 cells were plated on 35-mm dishes and transfected with WT Kir6.2 and F27S f-SUR1. Login to comment
125 ABCC7 p.Arg74Trp
X
ABCC7 p.Arg74Trp 23744072:125:136
status: NEW
view ABCC7 p.Arg74Trp details
ABCC8 p.Val187Asp
X
ABCC8 p.Val187Asp 23744072:125:153
status: NEW
view ABCC8 p.Val187Asp details
ABCC8 p.Ala116Pro
X
ABCC8 p.Ala116Pro 23744072:125:142
status: NEW
view ABCC8 p.Ala116Pro details
ABCC8 p.Glu128Lys
X
ABCC8 p.Glu128Lys 23744072:125:29
status: NEW
view ABCC8 p.Glu128Lys details
ABCC8 p.Asn24Lys
X
ABCC8 p.Asn24Lys 23744072:125:202
status: NEW
view ABCC8 p.Asn24Lys details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:125:20
status: NEW
view ABCC8 p.Phe27Ser details
At 10 òe;M, the F27S and E128K mutations exhibited the greatest improvement to nearly the level seen with 5 òe;M glibenclamide; R74W, A116P, and V187D showed moderate responses; whereas G7R and N24K, which have less severe processing defects (31), had weak responses (Fig. 1C). Login to comment
126 ABCC8 p.Val187Asp
X
ABCC8 p.Val187Asp 23744072:126:73
status: NEW
view ABCC8 p.Val187Asp details
ABCC8 p.Ala116Pro
X
ABCC8 p.Ala116Pro 23744072:126:62
status: NEW
view ABCC8 p.Ala116Pro details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:126:56
status: NEW
view ABCC8 p.Phe27Ser details
Dose-response relationships were further determined for F27S, A116P, and V187D. Login to comment
127 ABCC7 p.Arg74Trp
X
ABCC7 p.Arg74Trp 23744072:127:136
status: NEW
view ABCC7 p.Arg74Trp details
ABCC8 p.Val187Asp
X
ABCC8 p.Val187Asp 23744072:127:153
status: NEW
view ABCC8 p.Val187Asp details
ABCC8 p.Ala116Pro
X
ABCC8 p.Ala116Pro 23744072:127:142
status: NEW
view ABCC8 p.Ala116Pro details
ABCC8 p.Glu128Lys
X
ABCC8 p.Glu128Lys 23744072:127:29
status: NEW
view ABCC8 p.Glu128Lys details
ABCC8 p.Asn24Lys
X
ABCC8 p.Asn24Lys 23744072:127:202
status: NEW
view ABCC8 p.Asn24Lys details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:127:20
status: NEW
view ABCC8 p.Phe27Ser details
At 10 òe;M, the F27S and E128K mutations exhibited the greatest improvement to nearly the level seen with 5 òe;M glibenclamide; R74W, A116P, and V187D showed moderate responses; whereas G7R and N24K, which have less severe processing defects (31), had weak responses (Fig. 1C). Login to comment
128 ABCC8 p.Val187Asp
X
ABCC8 p.Val187Asp 23744072:128:73
status: NEW
view ABCC8 p.Val187Asp details
ABCC8 p.Ala116Pro
X
ABCC8 p.Ala116Pro 23744072:128:62
status: NEW
view ABCC8 p.Ala116Pro details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:128:56
status: NEW
view ABCC8 p.Phe27Ser details
Dose-response relationships were further determined for F27S, A116P, and V187D. Login to comment
129 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:129:184
status: NEW
view ABCC8 p.Phe27Ser details
Time Course and Duration of the Carbamazepine Rescue Effect-To characterize the carbamazepine effect further, we determined the time course and duration of the rescue effect using the F27S mutation as an example. Login to comment
131 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:131:184
status: NEW
view ABCC8 p.Phe27Ser details
Time Course and Duration of the Carbamazepine Rescue Effect-To characterize the carbamazepine effect further, we determined the time course and duration of the rescue effect using the F27S mutation as an example. Login to comment
136 ABCC8 p.Val187Asp
X
ABCC8 p.Val187Asp 23744072:136:111
status: NEW
view ABCC8 p.Val187Asp details
ABCC8 p.Ala116Pro
X
ABCC8 p.Ala116Pro 23744072:136:101
status: NEW
view ABCC8 p.Ala116Pro details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:136:95
status: NEW
view ABCC8 p.Phe27Ser details
In surface protein biotinylation experiments, there was a significant increase in biotinylated F27S, A116P, or V187D SUR1 in cells treated with carbamazepine or glibenclamide as compared with cells treated with vehicle alone (Fig. 3A). Login to comment
137 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:137:4
status: NEW
view ABCC8 p.Phe27Ser details
The F27S mutant was further analyzed by surface staining and chemiluminescence assays. Login to comment
138 ABCC8 p.Val187Asp
X
ABCC8 p.Val187Asp 23744072:138:111
status: NEW
view ABCC8 p.Val187Asp details
ABCC8 p.Ala116Pro
X
ABCC8 p.Ala116Pro 23744072:138:101
status: NEW
view ABCC8 p.Ala116Pro details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:138:95
status: NEW
view ABCC8 p.Phe27Ser details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:138:103
status: NEW
view ABCC8 p.Phe27Ser details
Surface staining of FLAG-tagged (N terminus) SUR1 showed a clear increase in surface expression of the F27S mutant upon Carbamazepine as a Novel KATP Channel Corrector JULY 19, 2013ߦVOLUME 288ߦNUMBER 29 JOURNAL OF BIOLOGICAL CHEMISTRY 20945 carbamazepine treatment, resembling that seen in cells treated with the sulfonylurea drug tolbutamide (Fig. 3B). Login to comment
139 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:139:4
status: NEW
view ABCC8 p.Phe27Ser details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:139:200
status: NEW
view ABCC8 p.Phe27Ser details
In addition, we quantified the amount of SUR1 surface expression using a chemiluminescence assay as described under "Materials and Methods" and observed a pronounced increase in surface expression of F27S mutant channels in response to 10 or 50 òe;M carbamazepine treatment (Fig. 3C). Login to comment
140 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:140:103
status: NEW
view ABCC8 p.Phe27Ser details
Surface staining of FLAG-tagged (N terminus) SUR1 showed a clear increase in surface expression of the F27S mutant upon Carbamazepine as a Novel KATP Channel Corrector JULY 19, 2013ߦVOLUME 288ߦNUMBER 29 JOURNAL OF BIOLOGICAL CHEMISTRY 20945 carbamazepine treatment, resembling that seen in cells treated with the sulfonylurea drug tolbutamide (Fig. 3B). Login to comment
141 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:141:200
status: NEW
view ABCC8 p.Phe27Ser details
In addition, we quantified the amount of SUR1 surface expression using a chemiluminescence assay as described under "Materials and Methods" and observed a pronounced increase in surface expression of F27S mutant channels in response to 10 or 50 òe;M carbamazepine treatment (Fig. 3C). Login to comment
142 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:142:88
status: NEW
view ABCC8 p.Phe27Ser details
To test this, we conducted metabolic pulse-chase experiments to monitor the kinetics of F27S mutant SUR1 maturation from the core-glycosylated to the complex-glycosylated band in cells treated with carbamazepine or the vehicle DMSO. Login to comment
144 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:144:88
status: NEW
view ABCC8 p.Phe27Ser details
To test this, we conducted metabolic pulse-chase experiments to monitor the kinetics of F27S mutant SUR1 maturation from the core-glycosylated to the complex-glycosylated band in cells treated with carbamazepine or the vehicle DMSO. Login to comment
145 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:145:146
status: NEW
view ABCC8 p.Phe27Ser details
Note that the low maturation efficiency of SUR1 from the core-glycosylated to the complex-glycosylated form observed in the carbamazepine-treated F27S mutant (b03;20% of pulse-labeled SUR1) is similar to the value obtained previously for WT SUR1 in experiments where pulse-labeled SUR1 was chased for up to 24 h (29, 30, 36). Login to comment
147 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:147:146
status: NEW
view ABCC8 p.Phe27Ser details
Note that the low maturation efficiency of SUR1 from the core-glycosylated to the complex-glycosylated form observed in the carbamazepine-treated F27S mutant (b03;20% of pulse-labeled SUR1) is similar to the value obtained previously for WT SUR1 in experiments where pulse-labeled SUR1 was chased for up to 24 h (29, 30, 36). Login to comment
171 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:171:69
status: NEW
view ABCC8 p.Phe27Ser details
A, COSm6 cells were transiently transfected with WT Kir6.2 and WT or F27S mutant SUR1 cDNAs and treated with 10 or 50 òe;M carbamazepine (C) or 5 òe;M glibenclamide (G) for 0, 1, 2, 4, 6, 10, 12, or 16 h. Panel i, blots showing cells treated with glibenclamide or carbamazepine for 1 h (left) when an effect on the upper band signal was first detected and for 6 h (right) when the effect began to plateau. Login to comment
173 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:173:69
status: NEW
view ABCC8 p.Phe27Ser details
A, COSm6 cells were transiently transfected with WT Kir6.2 and WT or F27S mutant SUR1 cDNAs and treated with 10 or 50 òe;M carbamazepine (C) or 5 òe;M glibenclamide (G) for 0, 1, 2, 4, 6, 10, 12, or 16 h. Panel i, blots showing cells treated with glibenclamide or carbamazepine for 1 h (left) when an effect on the upper band signal was first detected and for 6 h (right) when the effect began to plateau. Login to comment
176 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:176:29
status: NEW
view ABCC8 p.Phe27Ser details
WT without any treatment and F27S mutant treated with DMSO (0.1%) for 16 h are shown for comparison. Login to comment
178 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:178:29
status: NEW
view ABCC8 p.Phe27Ser details
WT without any treatment and F27S mutant treated with DMSO (0.1%) for 16 h are shown for comparison. Login to comment
181 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:181:0
status: NEW
view ABCC8 p.Phe27Ser details
F27S treated with DMSO for 16 h is shown for comparison. Login to comment
183 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:183:0
status: NEW
view ABCC8 p.Phe27Ser details
F27S treated with DMSO for 16 h is shown for comparison. Login to comment
186 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:186:13
status: NEW
view ABCC8 p.Phe27Ser details
We chose the F27S mutant for this analysis because it exhibited the greatest response to rescue by carbamazepine and has been shown previously to have WT-like gating properties (31). Login to comment
187 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:187:3
status: NEW
view ABCC8 p.Phe27Ser details
In F27S-transfected cells treated overnight with 10 òe;M carbamazepine, metabolic inhibition induced only a low level of efflux similar to that seen in vehicle-treated cells. Login to comment
188 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:188:13
status: NEW
view ABCC8 p.Phe27Ser details
We chose the F27S mutant for this analysis because it exhibited the greatest response to rescue by carbamazepine and has been shown previously to have WT-like gating properties (31). Login to comment
189 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:189:3
status: NEW
view ABCC8 p.Phe27Ser details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:189:62
status: NEW
view ABCC8 p.Phe27Ser details
This result indicates that carbamazepine does prevent rescued F27S channels from being activated by metabolic inhibition. Login to comment
191 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:191:49
status: NEW
view ABCC8 p.Phe27Ser details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:191:62
status: NEW
view ABCC8 p.Phe27Ser details
A progressive increase in efflux through rescued F27S channels over a 40-min period was observed with longer washout; the efflux level was nearly comparable with that seen in WT channels with 60-min washout (Fig. 6B). Login to comment
193 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:193:49
status: NEW
view ABCC8 p.Phe27Ser details
A progressive increase in efflux through rescued F27S channels over a 40-min period was observed with longer washout; the efflux level was nearly comparable with that seen in WT channels with 60-min washout (Fig. 6B). Login to comment
202 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:202:29
status: NEW
view ABCC8 p.Phe27Ser details
*, p b0d; 0.001 comparing F27S vehicle with various treatment groups by one-way analysisofvariancewithBonferroniposthoctest.ErrorbarsrepresentS.E.Unt, untransfected cells. Login to comment
204 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:204:24
status: NEW
view ABCC8 p.Phe27Ser details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:204:29
status: NEW
view ABCC8 p.Phe27Ser details
Carbamazepine increases F27S mutant channel surface expression by improving processing and maturation of the channel complex during biogenesis. Login to comment
205 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:205:32
status: NEW
view ABCC8 p.Phe27Ser details
A, COSm6 cells transfected with F27S SUR1 and WT Kir6.2 were pulse-labeled with Tran35 S-Label for an hour and chased for 0-4 h in regular medium. Login to comment
206 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:206:24
status: NEW
view ABCC8 p.Phe27Ser details
Carbamazepine increases F27S mutant channel surface expression by improving processing and maturation of the channel complex during biogenesis. Login to comment
207 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:207:32
status: NEW
view ABCC8 p.Phe27Ser details
A, COSm6 cells transfected with F27S SUR1 and WT Kir6.2 were pulse-labeled with Tran35 S-Label for an hour and chased for 0-4 h in regular medium. Login to comment
211 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:211:324
status: NEW
view ABCC8 p.Phe27Ser details
*, p b0d; 0.001 by Student`s t test. Error bars represent S.E. Carbamazepine as a Novel KATP Channel Corrector 20948 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 288ߦNUMBER 29ߦJULY 19, 2013 at SEMMELWEIS UNIV OF MEDICINE on December , upon extensive washout (b03;1 h), physiological function of rescued surface F27S channels was recovered nearly completely. Login to comment
213 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:213:103
status: NEW
view ABCC8 p.Phe27Ser details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:213:324
status: NEW
view ABCC8 p.Phe27Ser details
We tested this idea by examining the effects of carbamazepine and the KATP channel opener diazoxide on F27S channels using the 86 Rbaf9; assay. Login to comment
215 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:215:103
status: NEW
view ABCC8 p.Phe27Ser details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:215:126
status: NEW
view ABCC8 p.Phe27Ser details
However, combination of metabolic inhibitors and 200 òe;M diazoxide resulted in a significantly higher efflux through the F27S channels in cells treated overnight with 10 òe;M carbamazepine compared with cells treated with vehicle alone without washout (Fig. 6C). Login to comment
217 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:217:126
status: NEW
view ABCC8 p.Phe27Ser details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:217:164
status: NEW
view ABCC8 p.Phe27Ser details
To ensure that diazoxide and carbamazepine can be co-administered without compromising the rescue effect of carbamazepine, we compared the processing efficiency of F27S SUR1 in cells treated overnight with diazoxide, carbamazepine, or both together. Login to comment
219 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:219:164
status: NEW
view ABCC8 p.Phe27Ser details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:219:204
status: NEW
view ABCC8 p.Phe27Ser details
Our results show that although diazoxide abolished the chaperoning effect of either glibenclamide or tolbutamide it did not interfere with the ability of carbamazepine to correct the processing defect of F27S SUR1 (Fig. 6D). Login to comment
221 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:221:204
status: NEW
view ABCC8 p.Phe27Ser details
Our results show that although diazoxide abolished the chaperoning effect of either glibenclamide or tolbutamide it did not interfere with the ability of carbamazepine to correct the processing defect of F27S SUR1 (Fig. 6D). Login to comment
223 ABCC8 p.Ala116Pro
X
ABCC8 p.Ala116Pro 23744072:223:247
status: NEW
view ABCC8 p.Ala116Pro details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:223:238
status: NEW
view ABCC8 p.Phe27Ser details
We used human islets and beta-cells as well as rat insulinoma INS-1 cells for these experiments. Human islets obtained through the Integrated Islet Distribution Program were co-infected overnight with adenoviruses carrying Kir6.2 and WT, F27S, or A116P f-SUR1 cDNAs. Login to comment
225 ABCC8 p.Ala116Pro
X
ABCC8 p.Ala116Pro 23744072:225:247
status: NEW
view ABCC8 p.Ala116Pro details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:225:238
status: NEW
view ABCC8 p.Phe27Ser details
We used human islets and beta-cells as well as rat insulinoma INS-1 cells for these experiments. Human islets obtained through the Integrated Islet Distribution Program were co-infected overnight with adenoviruses carrying Kir6.2 and WT, F27S, or A116P f-SUR1 cDNAs. Login to comment
226 ABCC8 p.Ala116Pro
X
ABCC8 p.Ala116Pro 23744072:226:215
status: NEW
view ABCC8 p.Ala116Pro details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:226:140
status: NEW
view ABCC8 p.Phe27Ser details
As was observed in COSm6 cells, overnight glibenclamide and carbamazepine treatments led to a marked increase in the upper SUR1 band in the F27S mutant and an obvious albeit weaker increase in the upper band in the A116P mutant in whole islet lysates (Fig. 7A, panel i). Login to comment
228 ABCC8 p.Ala116Pro
X
ABCC8 p.Ala116Pro 23744072:228:215
status: NEW
view ABCC8 p.Ala116Pro details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:228:140
status: NEW
view ABCC8 p.Phe27Ser details
As was observed in COSm6 cells, overnight glibenclamide and carbamazepine treatments led to a marked increase in the upper SUR1 band in the F27S mutant and an obvious albeit weaker increase in the upper band in the A116P mutant in whole islet lysates (Fig. 7A, panel i). Login to comment
234 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:234:58
status: NEW
view ABCC8 p.Phe27Ser details
A, Western blot of SUR1 from COSm6 cells transfected with F27S SUR1 and WT Kir6.2 and treated with carbamazepine (CBZ), chloroquine (Chloroq), or both for 16 h (upper panel) or carbamazepine, Ly294002, or both for 16 h (lower panel) as indicated. Login to comment
236 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:236:58
status: NEW
view ABCC8 p.Phe27Ser details
B, Western blot of SUR1 from COSm6 cells transfected with F27S SUR1 and WT Kir6.2 and treated with carbamazepine or rapamycin (Rapa) or Liaf9; , both of which are autophagy inducers, for 16 h as indicated. Login to comment
237 ABCC8 p.Ala116Pro
X
ABCC8 p.Ala116Pro 23744072:237:264
status: NEW
view ABCC8 p.Ala116Pro details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:237:255
status: NEW
view ABCC8 p.Phe27Ser details
Carbamazepine as a Novel KATP Channel Corrector JULY 19, 2013ߦVOLUME 288ߦNUMBER 29 JOURNAL OF BIOLOGICAL CHEMISTRY 20949 Together, these results demonstrate that carbamazepine effectively improved the processing and surface expression of the F27S and A116P SUR1 trafficking-impaired mutant KATP channels in pancreatic beta-cells. Login to comment
238 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:238:58
status: NEW
view ABCC8 p.Phe27Ser details
B, Western blot of SUR1 from COSm6 cells transfected with F27S SUR1 and WT Kir6.2 and treated with carbamazepine or rapamycin (Rapa) or Liaf9; , both of which are autophagy inducers, for 16 h as indicated. Login to comment
239 ABCC8 p.Ala116Pro
X
ABCC8 p.Ala116Pro 23744072:239:264
status: NEW
view ABCC8 p.Ala116Pro details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:239:255
status: NEW
view ABCC8 p.Phe27Ser details
Carbamazepine as a Novel KATP Channel Corrector JULY 19, 2013ߦVOLUME 288ߦNUMBER 29 JOURNAL OF BIOLOGICAL CHEMISTRY 20949 Together, these results demonstrate that carbamazepine effectively improved the processing and surface expression of the F27S and A116P SUR1 trafficking-impaired mutant KATP channels in pancreatic beta-cells. Login to comment
254 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:254:0
status: NEW
view ABCC8 p.Phe27Ser details
F27S cells were treated overnight (O.N.) with 10 òe;M carbamazepine, and carbamazepine was removed 15, 30, or 60 min (washout) prior to incubation with metabolic inhibitors. Login to comment
256 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:256:0
status: NEW
view ABCC8 p.Phe27Ser details
F27S cells were treated overnight (O.N.) with 10 òe;M carbamazepine, and carbamazepine was removed 15, 30, or 60 min (washout) prior to incubation with metabolic inhibitors. Login to comment
258 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:258:29
status: NEW
view ABCC8 p.Phe27Ser details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:258:264
status: NEW
view ABCC8 p.Phe27Ser details
*, p b0d; 0.001 comparing F27S vehicle (Veh) with various treatment groups by one-way analysis of variance with Bonferroni post hoc test. Error bars represent S.E. D, Western blots show the effects of different drug combinations on the processing efficiency of F27S SUR1 co-expressed with WT Kir6.2 in COSm6 cells. Login to comment
260 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:260:29
status: NEW
view ABCC8 p.Phe27Ser details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:260:181
status: NEW
view ABCC8 p.Phe27Ser details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:260:264
status: NEW
view ABCC8 p.Phe27Ser details
Note that although diazoxide nearly abolished the rescue effect of glibenclamide or tolbutamide it had no effect on the ability of carbamazepine to correct the processing defect of F27S SUR1. Login to comment
262 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:262:181
status: NEW
view ABCC8 p.Phe27Ser details
Note that although diazoxide nearly abolished the rescue effect of glibenclamide or tolbutamide it had no effect on the ability of carbamazepine to correct the processing defect of F27S SUR1. Login to comment
265 ABCC8 p.Ala116Pro
X
ABCC8 p.Ala116Pro 23744072:265:181
status: NEW
view ABCC8 p.Ala116Pro details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:265:173
status: NEW
view ABCC8 p.Phe27Ser details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:265:494
status: NEW
view ABCC8 p.Phe27Ser details
A, panel i, representative SUR1 blots from uninfected human islets (probed with anti-SUR1 antibody) and human islets infected with adenoviruses carrying WT Kir6.2 and WT or F27S or A116P mutant f-SUR1 cDNAs (probed with anti-FLAG antibody) and treated with DMSO, 5 òe;M glibenclamide (Glib), or 10 òe;M carbamazepine (CBZ) for 16 h. Panel ii, representative whole-cell patch clamp recordings measuring KATP current density in control and drug-treated human beta-cells infected with the F27S mutant viruses (recordings are from two cells with similar membrane capacitance of b03;10 picofarads (pF)). Login to comment
267 ABCC8 p.Ala116Pro
X
ABCC8 p.Ala116Pro 23744072:267:181
status: NEW
view ABCC8 p.Ala116Pro details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:267:173
status: NEW
view ABCC8 p.Phe27Ser details
ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:267:494
status: NEW
view ABCC8 p.Phe27Ser details
A, panel i, representative SUR1 blots from uninfected human islets (probed with anti-SUR1 antibody) and human islets infected with adenoviruses carrying WT Kir6.2 and WT or F27S or A116P mutant f-SUR1 cDNAs (probed with anti-FLAG antibody) and treated with DMSO, 5 òe;M glibenclamide (Glib), or 10 òe;M carbamazepine (CBZ) for 16 h. Panel ii, representative whole-cell patch clamp recordings measuring KATP current density in control and drug-treated human beta-cells infected with the F27S mutant viruses (recordings are from two cells with similar membrane capacitance of b03;10 picofarads (pF)). Login to comment
290 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:290:121
status: NEW
view ABCC8 p.Phe27Ser details
This suggests that diazoxide may antagonize the inhibitory effect of carbamazepine to potentiate the function of rescued F27S channels. Login to comment
292 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:292:121
status: NEW
view ABCC8 p.Phe27Ser details
This suggests that diazoxide may antagonize the inhibitory effect of carbamazepine to potentiate the function of rescued F27S channels. Login to comment
296 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:296:249
status: NEW
view ABCC8 p.Phe27Ser details
Feasibility of the carbamazepine and diazoxide combination therapy strategy is further supported by our finding that the two drugs can be co-applied to cells without compromising the ability of carbamazepine to rescue the trafficking defects of the F27S mutant (Fig. 6D). Login to comment
298 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:298:249
status: NEW
view ABCC8 p.Phe27Ser details
Feasibility of the carbamazepine and diazoxide combination therapy strategy is further supported by our finding that the two drugs can be co-applied to cells without compromising the ability of carbamazepine to rescue the trafficking defects of the F27S mutant (Fig. 6D). Login to comment
301 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:301:51
status: NEW
view ABCC8 p.Phe27Ser details
Although our study focused mostly on one mutation (F27S) that responded well to carbamazepine, there are many additional congenital hyperinsulinism-associated SUR1 TMD0 mutations waiting to be tested (4). Login to comment
303 ABCC8 p.Phe27Ser
X
ABCC8 p.Phe27Ser 23744072:303:51
status: NEW
view ABCC8 p.Phe27Ser details
Although our study focused mostly on one mutation (F27S) that responded well to carbamazepine, there are many additional congenital hyperinsulinism-associated SUR1 TMD0 mutations waiting to be tested (4). Login to comment